Sonnet BioTherapeutics Holdings, Inc.
SONNDelisted Dec 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001106838
Sonnet BioTherapeutics Holdings, Inc. was delisted on Dec 2, 2025; its insiders filed their last Form 4 on Dec 4, 2025; 27 institutions reported holding it in 13F filings for Q3 2025, worth $3.53M in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Sonnet BioTherapeutics Holdings, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 10 | 11 | +1 |
| Shares | 63.3K | 586.2K | +522.9K (+825.5%) |
| Value | $117.6K | $550.0K | +$432.3K (+367.5%) |
New holders (4)
Institutions that held Sonnet BioTherapeutics Holdings, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 272,000 | $255.0K | 0.01% |
| Sabby Management, LLC | 238,395 | $223.5K | 2.97% |
| Geode Capital Management, LLC | 16,704 | $15.7K | 0.00% |
| UBS Group AG | 3,997 | $3.75K | 0.00% |
Sold out (3)
Institutions that held Sonnet BioTherapeutics Holdings, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Susquehanna International Group, LLP | 34,453 | $64.1K |
| Citigroup Inc | 38 | $71 |
| Wells Fargo & Company | 22 | $41 |